Parapneumonic Pleural Effusions And Empyema Thoracis

A parapneumonic effusion refers to the accumulation of exudative pleural fluid associated with an ipsilateral lung infection, mainly pneumonia. Parapneumonic effusions are mainly associated with bacterial infections.Parapneumonic pleural effusions are classified into:Pleural effusions are common in patients who develop pneumonia. At least 40-60% of patients with bacterial pneumonia will develop a pleural effusion of varying severity. Today, these parapneumonic effusions are not common because of prompt antibiotic therapy. However, in some patients the parapneumonic effusion becomes fibrinous and later develops an infection, resulting in an empyema.

[1]  G. Suh,et al.  Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia , 2018, Infection & chemotherapy.

[2]  W. Liang,et al.  A meta-analysis of video-assisted thoracoscopic decortication versus open thoracotomy decortication for patients with empyema. , 2017, Journal of thoracic disease.

[3]  C. Gilbert,et al.  Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens , 2017, Current opinion in pulmonary medicine.

[4]  J. Huggins,et al.  The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions , 2016, Thorax.

[5]  N. Dean,et al.  Pleural Effusions at First ED Encounter Predict Worse Clinical Outcomes in Patients With Pneumonia. , 2016, Chest.

[6]  N. Dean,et al.  Pneumonia and empyema: causal, casual or unknown. , 2015, Journal of thoracic disease.

[7]  F. Gleeson,et al.  A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. , 2014, Chest.

[8]  J. Sheu,et al.  Clinical Importance of Angiogenic Cytokines, Fibrinolytic Activity and Effusion Size in Parapneumonic Effusions , 2013, PloS one.

[9]  J. M. Porcel,et al.  Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. , 2012, European journal of internal medicine.

[10]  Yuwei Zhu,et al.  Emergence of parapneumonic empyema in the USA , 2011, Thorax.

[11]  C. Chu,et al.  Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes. , 2007, Hong Kong medical journal = Xianggang yi xue za zhi.

[12]  A. Arifi,et al.  Post‐pneumonectomy empyema: Current management strategies , 2005, ANZ journal of surgery.

[13]  B. Littenberg,et al.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. , 2000, Chest.

[14]  J. Sanchis,et al.  Factores predictivos del engrosamiento pleural residual en el derrame pleural metaneumónico , 1999 .

[15]  M. Hauser,et al.  Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome. , 1999, The Journal of thoracic and cardiovascular surgery.

[16]  P. Hsueh,et al.  Empyema thoracis and lung abscess caused by viridans streptococci. , 1997, American journal of respiratory and critical care medicine.

[17]  A. Arroliga,et al.  Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial. , 1996, Chest.

[18]  W. Webb,et al.  Pleural exudates and transudates: diagnosis with contrast-enhanced CT. , 1994, Radiology.

[19]  G. Nash,et al.  Parietal pleural changes in empyema: appearances at CT. , 1990, Radiology.

[20]  J. M. Porcel,et al.  Parapneumonic Effusions and Empyema , 1985, Medicina clinica.

[21]  J. Bartlett,et al.  Bacteriology of empyema. , 1974, Lancet.